GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GlaxoSmithKline (GSK) has announced the purchase of 243,000 of its own ordinary shares ...

India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for its specialty medicine portfolio. The Indian unit of British drugmaker GSK ...

Net Sales at Rs 973.63 crore in September 2025 down 2.64% from Rs. 1,000.05 crore in September 2024. Quarterly Net Profit at ...

Pharmaceutical giant GlaxoSmithKline tapped Sidley Austin partner Dan Troy to join the company as senior vice president and general counsel on Sept. 2. Troy, a Washington- and New York-based lawyer ...

February was a wild month as coronavirus fears drove the pharma's stock price up and down. On Feb. 5, GlaxoSmithKline reported fourth-quarter 2019 earnings that fell short of analysts' expectations.

The global renal anemia market is experiencing significant growth, driven by advancements in therapeutic options, increased diagnostic accuracy, and enhanced healthcare investments in the U.S., Europe ...

Last week GlaxoSmithKline announced that its CEO, Sir Andrew Witty, would be stepping down from his post in early 2017. As outlined by the Financial Times, his tenure at GSK has been turbulent.

GlaxoSmithKline's fourth-quarter sales and profits weren't particularly encouraging, but this solitary aspect could signal that it's put the worst in the rearview mirror. However, GlaxoSmithKline's ...

Indoor dining, workout classes, concerts. These once commonplace events are coming back into daily life. But because of Covid-19, everyone now has a different level of comfort. What happens in the ...

Drug maker GlaxoSmithKline PLC said Wednesday it would lay off hundreds of its U.S. workers to reduce costs and to streamline its research and drug-marketing operations by the end of 2015. The layoffs ...